Follow
Stephen Fowler
Stephen Fowler
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
14312021
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
DE Shaw, AR Sousa, SJ Fowler, LJ Fleming, G Roberts, J Corfield, ...
European Respiratory Journal 46 (5), 1308-1321, 2015
5712015
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ...
European Respiratory Journal 49 (4), 2017
5172017
Dysfunctional breathing: a review of the literature and proposal for classification
R Boulding, R Stacey, R Niven, SJ Fowler
European Respiratory Review 25 (141), 287-294, 2016
3082016
Application of’omics technologies to biomarker discovery in inflammatory lung diseases
CE Wheelock, VM Goss, D Balgoma, B Nicholas, J Brandsma, PJ Skipp, ...
European Respiratory Journal 42 (3), 802-825, 2013
2932013
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ...
Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017
2882017
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
MedRxiv, 2021.06. 15.21258542, 2021
2492021
The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts
L Fleming, C Murray, AT Bansal, S Hashimoto, H Bisgaard, A Bush, ...
European Respiratory Journal 46 (5), 1322-1333, 2015
2302015
Exhaled breath analysis: a review of ‘breath-taking’methods for off-line analysis
O Lawal, WM Ahmed, TME Nijsen, R Goodacre, SJ Fowler
Metabolomics 13 (10), 1-16, 2017
2292017
Non-invasive phenotyping using exhaled volatile organic compounds in asthma
B Ibrahim, M Basanta, P Cadden, D Singh, D Douce, A Woodcock, ...
Thorax 66 (9), 804-809, 2011
2172011
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2082022
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RC Group
Lancet (London, England) 397 (10274), 605, 2021
2082021
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
SJ Fowler, J French, NJ Screaton, J Foweraker, A Condliffe, CS Haworth, ...
European Respiratory Journal 28 (6), 1204-1210, 2006
1902006
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
J Chalmers, H Abo-Leyah, H Loftus, M Spears, ...
Lancet 397 (10285), 1637-1645, 2021
1892021
A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED
CHS Kuo, S Pavlidis, M Loza, F Baribaud, A Rowe, I Pandis, U Hoda, ...
American Journal of Respiratory And Critical Care Medicine, 2016
1842016
Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial
SAFC Mitchell, R Garrod, L Clark, A Douiri, SM Parker, J Ellis, SJ Fowler, ...
Thorax 72 (2), 129-136, 2017
1802017
Taking your breath away: metabolomics breathes life in to personalized medicine
NJW Rattray, Z Hamrang, DK Trivedi, R Goodacre, SJ Fowler
Trends in biotechnology 32 (10), 538-548, 2014
1692014
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers
M Basanta, RM Jarvis, Y Xu, G Blackburn, R Tal-Singer, A Woodcock, ...
Analyst 135 (2), 315-320, 2010
1552010
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
Z Jevnikar, J Östling, E Ax, J Calvén, K Thörn, E Israelsson, L Öberg, ...
Journal of Allergy and Clinical Immunology 143 (2), 577-590, 2019
1532019
“T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
S Pavlidis, K Takahashi, FNK Kwong, J Xie, U Hoda, K Sun, ...
European Respiratory Journal 53 (1), 2019
1462019
The system can't perform the operation now. Try again later.
Articles 1–20